Dow-DuPont's $77 Billion Deal Wins EU Approval

The transcript discusses Du Pont's significant concessions to gain EU approval for a merger, including selling parts of its business. It highlights the impact on other industry mergers, such as Bayer-Monsanto and Syngenta-Chemchina, which are also under EU scrutiny. The text also covers EU-US antitrust relations, focusing on the challenges faced by EU Commissioner Vestager during her US visit amid leadership vacancies in US antitrust bodies.

What major action did Du Pont take to secure EU approval?

• Opened new research facilities

• Sold parts of its business

• Increased its workforce

• Acquired a new company

Why was the European Commission concerned about Du Pont's merger?

• Potential job losses

• Lack of competition in the market

• Impact on environmental regulations

• Decrease in innovation

What is the status of the Bayer and Monsanto merger in relation to the EU approval process?

• Already approved

• In the late stage of approval

• Not yet notified

• Rejected by the EU

What challenge does Margareta Vestager face during her visit to the US?

• Protests against EU policies

• Language barriers

• Technical issues with presentations

• Lack of counterparts to meet

What past decision by Vestager might lead to US criticism?

• Tax decision involving Apple

• Approval of a major merger

• Support for a US company

• Ban on a US product